Equivalent results (decreased promoter activity and mRNA levels) were obtained for VHL-i primary ccRCC cells expressing only HIF-2α (MM, Supplementary Fig. 4c, d). This evidence concerns the gene VHL and nonpapillary renal cell carcinoma.